Skip to main content

Main menu

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Peer reviewer login
  • Journal club
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Peer reviewer login
  • Journal club
  • Alerts
  • Subscriptions

Book review: Hodson and Geddes’ Cystic Fibrosis

Alex Horsley
Breathe 2016 12: 91-92; DOI: 10.1183/20734735.000216
Alex Horsley
1Centre for Respiratory Medicine and Allergy, Institute of Inflammation and Repair, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK
2Manchester Adult Cystic Fibrosis Centre, University Hospital of South Manchester NHS Foundation Trust, Manchester, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Alexander.horsley@manchester.ac.uk
  • Article
  • Info & Metrics
  • PDF
Loading
Editors: Andrew Bush, Diana Bilton and Margaret Hodson; CRC Press; 699 pages; ISBN: 978-1444180008

Abstract

Book review: Hodson and Geddes' Cystic Fibrosis (4th edition) edited by A. Bush et al. http://ow.ly/Y7eSP

Embedded Image

With the fourth edition of this now eponymous tome, the new editors have once again brought together a wide range of over 80 experts in different aspects of cystic fibrosis (CF) care. The remit of this book is both wide ranging and deep, stretching to 49 chapters over 700 pages. The history of CF care and the people who have shaped it are described in their own chapter, but are, in fact, also laid bare in the evolving editions of this book. To get a feel for the incredible advances in basic understanding of and treatments available for CF, you only have to compare the length and contents of the current (fourth) edition with that of the second edition, published only 15 years earlier (had a copy of the first edition had been available for comparison, it’s doubtless that the differences would have appeared even starker). In no other field of respiratory medi­cine has there been such a revolution in clinical practice and outcomes. This disease of childhood, with a median life expectancy of only 24 years at the start of the century, has been transformed into a chronic disease of adulthood. Patient numbers have swelled accordingly, but with improvements in life expectancy have also come challenges ­created by managing a host of additional CF and treatment-related complications.

The latest edition of Hodson and Geddes’ Cystic Fibrosis very much reflects this changing landscape. Much of the basics of CF medicine are perhaps covered elsewhere, including in national guidelines or other more concise texts. But this book is not one for the practitioner with a casual interest in CF healthcare. Only in a book of this magnitude can the more detailed but demanding topics be addressed. Chapters on growing old with CF, sleep, noninvasive ventilation and palliative care very much reflect the changing burden of disease, and are important topics that have so far received relatively little attention. A marker of how much things have changed is the lack of patient segregation in the earlier edition. This is a core principle of CF care today. Understanding the microbiology of CF lung disease, detecting infection early and preventing patient–patient transmission are all covered separately in three excellent and detailed chapters.

What has not changed in the intervening years is that CF remains one of the most diverse, challenging and rewarding areas of respiratory medicine. CF care is also an exemplar of the multidisciplinary team approach. It is refreshing to see, alongside the grandees of CF medicine, important contributions from physiotherapists, dietitians, nurses, psychologists, diabetologists, otolaryngologists, gastroenterologists, palliative care specialists and a host of others. Most notable among these are the patients and parents who have written a chapter on their own experiences of the disease. Even veteran and hardened professionals will find it hard not to melt at these first-hand accounts, and they help to put all the research and endeavour into perspective.

As our experience of the disease has evolved, CF has become very much at the forefront of clinical and basic research into the mechanisms of lung disease, work that is now filtering into other areas of respiratory medicine. This is not neglected here either, with chapters dealing specifically with trial outcomes, computed tomography and multiple-breath washout techniques. The most important and transformative recent advances in CF, however, are the development of cystic fibrosis transmembrane conductance regulator modulator and chaperone therapies, barely dreamt of 15 years ago. This is now a rapidly evolving field, with new compounds coming to trial all the time. A large volume like this, which takes time to compile, is perhaps not the best place to source up-to-date developments in this field. Indeed some chapters make reference to “future” studies that have already been published (gene therapy for example). This will always be a weakness of traditional text books, but in compensation the basic science is exhaustively ­covered.

Overall, this book is as comprehensive and definitive a guide to the state of clinical experience and practice in CF as it is possible to come by. It is a sweeping epic that takes in both the past and the future, and provides a reference for even the most experienced CF specialist to learn from or to reach for in times of trouble.

Footnotes

  • Conflict of interest A. Horsley reports grants from National Institute of Health Research during the conduct of the study; grants from Vertex Pharmaceuticals and personal fees from Oxford University Press, outside the submitted work. A. Horsley is an editor and author of the ORML handbook on CF.

  • ©ERS 2016

Breathe articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.

PreviousNext
Back to top
Vol 12 Issue 1 Table of Contents
Breathe: 12 (1)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Book review: Hodson and Geddes’ Cystic Fibrosis
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Book review: Hodson and Geddes’ Cystic Fibrosis
Alex Horsley
Breathe Mar 2016, 12 (1) 91-92; DOI: 10.1183/20734735.000216

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Book review: Hodson and Geddes’ Cystic Fibrosis
Alex Horsley
Breathe Mar 2016, 12 (1) 91-92; DOI: 10.1183/20734735.000216
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Footnotes
  • Info & Metrics
  • PDF

Subjects

  • CF and non-CF bronchiectasis
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Lung cancer screening by volume CT
  • In pursuit of the primary
  • A rare complication in a case of nonsmall cell lung carcinoma
Show more Expert opinion

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About Breathe

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Intructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN: 1810-6838
Online ISSN: 2073-4735

Copyright © 2023 by the European Respiratory Society